# TADALAFIL
> **ANDA210572** · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL RX · Approved 2019-02-05
## Drug
- **FDA Application Number:** ANDA210572
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TADALAFIL
- **Generic name:** TADALAFIL
- **Active ingredients:** TADALAFIL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CHARTWELL RX
- **Manufacturer:** Lupin Pharmaceuticals, Inc.
- **First approval:** 2019-02-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210572)
---
*AI Analytics · CC0 1.0*